Effect of Preoperative CIMT on Hemodynamics During Liver Transplantation

Recruiting Observational Study
Liver Transplantation Carotid Intima-media Thickness
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
54 (estimated)
Sponsor
Dicle University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Candidates for liver transplantation (CT) carry an increased risk of cardiovascular disease (CVD) due to underlying end-stage liver disease (ESHD) and immunosuppressive drugs used post-transplantation. CVD is a significant cause of long-term mortality after CT \[1\] \[2\]. Carotid Intima-Media Thickness (CIMT), a subclinical marker of atherosclerosis in the preoperative period, is a non-invasive m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 65 years * Scheduled for elective liver transplantation surgery * Completed preoperative carotid intima-media thickness (CIMT) ultrasonographic measurement * Patients with signed informed consent for data collection Exclusion Criteria: * Patients…
Contacts

ibrahim andan, Asst. Prof.

+905059051167

ibrahimandan@hotmail.com

CONTACT

ayhan kaydu, Assoc. Prof.

+90 505 556 79 39

akaydu@hotmail.com

CONTACT